Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TIVA vs Balanced Anesthesia for FVEP Monitoring in Sellar Tumor Resection
NCT04725032Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jan 2021
- Primary completion
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of sevoflurane in sellar tumor (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: N2 amplitudes of Flash Visual Evoked Potentials (FVEPs). Started Jan 2021; status: recruiting.
02
Drugs
sevoflurane
03
Conditions
sellar tumor
Beyond the preview
Go deeper on NCT04725032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04725032.